Atlas Trials

First-in-human Study of S-588210 (S-488210+S-488211)

Clinical trial NCT04316689 · COMPLETED

Trial details

NCT number
NCT04316689
Sponsor
Shionogi
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Lung CancerHead and Neck CancerBladder CancerEsophageal CancerMesothelioma
Start date
2019-07-30
Primary completion
2021-09-22
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.